You are here

Home › Use of Covid antiviral medicineby infected Americans remains low --study › Use of Covid antiviral medicineby infected Americans remains low --study

Use of Covid antiviral medicineby infected Americans remains low --study

Primary tabs

Use of Covid antiviral medicineby infected Americans remains low --study

Thu, 2023-12-28 18:10 — mike kraft

 

COVID antiviral uptake low among eligible Americans Over the course of the study, most participants were eligible for antiviral use. CIDRAP

A new report published in Open Forum Infectious Diseases demonstrates that, despite the proven effectiveness of Paxlovid and molnupiravir against severe COVID-19 outcomes, uptake of these two antivirals remains low among Americans with COVID.

...

 

Country / Region Tags: 
United States
General Topic Tags: 
COVID-19
Treatments
Disease
Health
Public Attitudes
Public Health
Research
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report
Groups this Group Post belongs to: 
- Private group -
Workflow history
Revision ID Field name Date Old state New state name By Comment Operations
No state No state
howdy folks
Page loaded in 0.452 seconds.